Spots Global Cancer Trial Database for refractory glioblastoma
Every month we try and update this database with for refractory glioblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM | NCT04003649 | Recurrent Gliob... Refractory Glio... | IL13Ralpha2-spe... Ipilimumab Nivolumab Quality-of-Life... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM | NCT03149575 | Glioblastoma Mu... Glioblastoma Glioma GBM Brain Cancer | VAL-083, Dianhy... Physician's Cho... Physician's Cho... Physician's Cho... | 18 Years - | Kintara Therapeutics, Inc. | |
B7-H3 CAR-T for Recurrent or Refractory Glioblastoma | NCT04077866 | Recurrent Gliob... Refractory Glio... | Temozolomide B7-H3 CAR-T | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma | NCT02208362 | Recurrent Gliob... Recurrent Malig... Recurrent WHO G... Recurrent WHO G... Refractory Glio... Refractory Mali... Refractory WHO ... Refractory WHO ... | IL13Ralpha2-spe... IL13Ralpha2-spe... Laboratory Biom... Magnetic Resona... Magnetic Resona... Quality-of-Life... | 12 Years - 75 Years | City of Hope Medical Center | |
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma | NCT04385173 | Recurrent Gliob... Refractory Glio... | B7-H3 CAR-T Temozolomide | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma | NCT04674527 | Refractory Glio... | Elemene Temozolomide | 18 Years - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM | NCT04003649 | Recurrent Gliob... Refractory Glio... | IL13Ralpha2-spe... Ipilimumab Nivolumab Quality-of-Life... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma | NCT01478178 | Glioma Glioblastoma Glioblastoma Mu... GBM Brain Cancer | VAL-083 (Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting | NCT02717962 | Glioma Glioblastoma Glioblastoma Mu... GBM Brain Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. |